# NeuroOne Medical Technologies Corporation (NMTC)

Source: https://www.quantisnow.com/company/NMTC
Generated: 2026-11-18T17:01:41.229Z

- Ticker: NMTC
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Medical/Dental Instruments
- SEC CIK: 0001500198
- Website: n1mtc.com

## About

NeuroOne Medical Technologies Corporation operates as a medical technology company. It focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and other related brain related disorders. NeuroOne Medical Technologies Corporation has a strategic partnership with RBC Medical Innovations to develop and manufacture a radiofrequency generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.

## Latest NMTC news and filings

- 2026-10-29 12:00 UTC [NeuroOne® Announces Peer-Reviewed Publication of Initial Clinical Experience with OneRF® Trigeminal Nerve Ablation System](https://www.quantisnow.com/insight/neuroone-announces-peer-reviewed-publication-of-initial-clinical-experience-with-onerf-6762579)
- 2026-10-22 12:31 UTC [NeuroOne Secures First Pharmaceutical Industry Purchase Order for StereoCED™ Drug Delivery Platform to Support Tier 1 Global Pharmaceutical Company's Research Program](https://www.quantisnow.com/insight/neuroone-secures-first-pharmaceutical-industry-purchase-order-for-stereoced-drug-6754578)
- 2026-10-08 20:01 UTC [NeuroOne® Joins Dartmouth-Led Research Team on $1 Million NIH Grant to Advance Neurotransmitter Sensing Technology](https://www.quantisnow.com/insight/neuroone-joins-dartmouth-led-research-team-on-1-million-nih-grant-6741699)
- 2026-10-05 13:20 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-results-of-6736254)
- 2026-10-05 13:17 UTC [Earnings Date] [NeuroOne Reports Preliminary Fiscal Q4 Product Revenue Growth of 38.4%; Secures Record $4.5 Million Purchase Order](https://www.quantisnow.com/insight/neuroone-reports-preliminary-fiscal-q4-product-revenue-growth-of-384-6736248)
- 2026-09-17 13:05 UTC [NeuroOne® Expands U.S. Commercialization of FDA-Cleared OneRF® Trigeminal Nerve Ablation System with New Southern California Distribution Agreement](https://www.quantisnow.com/insight/neuroone-expands-us-commercialization-of-fda-cleared-onerf-trigeminal-nerve-ablation-6718673)
- 2026-09-08 12:31 UTC [Insider Buy] [Chief Business Officer Wambeke David J. bought $66,999 worth of shares (33,333 units at $2.01), increasing direct ownership by 20% to 199,999 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-business-officer-wambeke-david-j-bought-66999-worth-of-6707689)
- 2026-08-28 21:29 UTC [SEC Form 4] [SEC Form 4 filed by Chief Administrative Officer Johns Emily J.](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-administrative-officer-johns-emily-6698739)
- 2026-08-28 21:04 UTC [SEC Form 4] [SEC Form 4 filed by Chief Financial Officer Volker Christopher](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-financial-officer-volker-christopher-6698661)
- 2026-08-28 21:00 UTC [SEC Form 4] [SEC Form 4 filed by Market Development Director Christianson Mark](https://www.quantisnow.com/insight/sec-form-4-filed-by-market-development-director-christianson-mark-6698625)
- 2026-08-28 20:57 UTC [SEC Form 4] [SEC Form 4 filed by Chief Technology Officer Mertens Steve](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-technology-officer-mertens-steve-6698606)
- 2026-08-28 20:51 UTC [SEC Form 4] [SEC Form 4 filed by CEO & President Rosa David A](https://www.quantisnow.com/insight/sec-form-4-filed-by-ceo-president-rosa-david-a-6698591)
- 2026-08-27 13:05 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-other-events-6696660)
- 2026-08-13 12:20 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by NeuroOne Medical Technologies Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-neuroone-medical-technologies-corporation-6679482)
- 2026-08-13 12:15 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-results-of-6679474)
- 2026-07-14 20:30 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by NeuroOne Medical Technologies Corporation](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-neuroone-medical-technologies-6636951)
- 2026-07-14 20:28 UTC [SEC Form 3] [New insider Pratt Brian claimed ownership of 1,085,934 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-pratt-brian-claimed-ownership-of-1085934-shares-sec-6636909)
- 2026-07-02 20:39 UTC [SEC Form 4] [Market Development Director Christianson Mark sold $31,773 worth of shares (10,000 units at $3.18), decreasing direct ownership by 33% to 20,692 units (SEC Form 4)](https://www.quantisnow.com/insight/market-development-director-christianson-mark-sold-31773-worth-of-shares-6626000)
- 2026-06-12 20:45 UTC [SEC Form 424B5] [SEC Form 424B5 filed by NeuroOne Medical Technologies Corporation](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-neuroone-medical-technologies-corporation-6600849)
- 2026-06-12 20:45 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-other-events-6600834)
- 2026-06-12 20:32 UTC [SEC Form 10-Q] [Amendment: SEC Form 10-Q/A filed by NeuroOne Medical Technologies Corporation](https://www.quantisnow.com/insight/amendment-sec-form-10-qa-filed-by-neuroone-medical-technologies-corporation-6600730)
- 2026-05-29 20:30 UTC [SEC Form SD filed by NeuroOne Medical Technologies Corporation](https://www.quantisnow.com/insight/sec-form-sd-filed-by-neuroone-medical-technologies-corporation-6579507)
- 2026-05-29 20:30 UTC [SEC Form SD filed by NeuroOne Medical Technologies Corporation](https://www.quantisnow.com/insight/sec-form-sd-filed-by-neuroone-medical-technologies-corporation-6579463)
- 2026-05-22 20:30 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-non-reliance-on-6570144)
- 2026-05-12 12:15 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by NeuroOne Medical Technologies Corporation](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-neuroone-medical-technologies-corporation-6546839)
- 2026-05-12 12:10 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-results-of-6546814)
- 2026-05-04 12:30 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-other-events-6528209)
- 2026-04-30 12:30 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-leadership-update-6523165)
- 2026-04-22 00:18 UTC [SEC Form SCHEDULE 13G filed by NeuroOne Medical Technologies Corporation](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-neuroone-medical-technologies-corporation-6509104)
- 2026-04-14 12:30 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-amendments-to-6498925)
- 2026-04-07 17:46 UTC [SEC Form 4] [SEC Form 4 filed by Mills Jason Richard](https://www.quantisnow.com/insight/sec-form-4-filed-by-mills-jason-richard-6490976)
- 2026-04-07 17:38 UTC [SEC Form 4] [SEC Form 4 filed by Mathiesen Jeffrey S](https://www.quantisnow.com/insight/sec-form-4-filed-by-mathiesen-jeffrey-s-6490971)
- 2026-04-07 17:28 UTC [SEC Form 4] [SEC Form 4 filed by Buckman Paul](https://www.quantisnow.com/insight/sec-form-4-filed-by-buckman-paul-6490961)
- 2026-04-07 17:22 UTC [SEC Form 4] [SEC Form 4 filed by Andrle Edward](https://www.quantisnow.com/insight/sec-form-4-filed-by-andrle-edward-6490956)
- 2026-04-03 20:45 UTC [SEC Form 8-K] [NeuroOne Medical Technologies Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits](https://www.quantisnow.com/insight/neuroone-medical-technologies-corporation-filed-sec-form-8-k-leadership-update-6487897)
- 2026-04-01 20:11 UTC [SEC Form 4] [SEC Form 4 filed by Christianson Mark](https://www.quantisnow.com/insight/sec-form-4-filed-by-christianson-mark-6481928)
- 2026-04-01 20:08 UTC [SEC Form 4] [SEC Form 4 filed by Mertens Steve](https://www.quantisnow.com/insight/sec-form-4-filed-by-mertens-steve-6481884)
- 2026-04-01 20:01 UTC [SEC Form 4] [SEC Form 4 filed by Rosa David A](https://www.quantisnow.com/insight/sec-form-4-filed-by-rosa-david-a-6481739)
- 2026-03-16 19:30 UTC [SEC Form 4] [Business Development Director Christianson Mark sold $734 worth of shares (917 units at $0.80), decreasing direct ownership by 0.43% to 214,283 units (SEC Form 4)](https://www.quantisnow.com/insight/business-development-director-christianson-mark-sold-734-worth-of-shares-6449112)
- 2026-03-12 19:58 UTC [SEC Form 4] [Business Development Director Christianson Mark sold $10,976 worth of shares (13,720 units at $0.80), decreasing direct ownership by 6% to 215,200 units (SEC Form 4)](https://www.quantisnow.com/insight/business-development-director-christianson-mark-sold-10976-worth-of-shares-6444206)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/NMTC
- Earnings history: https://www.quantisnow.com/earnings/NMTC
- Dividend history: https://www.quantisnow.com/dividends/NMTC
- Insider transactions: https://www.quantisnow.com/insiders/NMTC
- Options chain: https://www.quantisnow.com/options/NMTC
- SEC 8-K filings only: https://www.quantisnow.com/company/NMTC/8-k
- RSS and alerts for NMTC: https://www.quantisnow.com/docs/rss-feeds.md
